Concepts (231)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Electric Stimulation Therapy | 5 | 2018 | 127 | 1.110 |
Why?
|
| Epilepsy, Temporal Lobe | 12 | 2017 | 109 | 1.100 |
Why?
|
| Electroencephalography | 26 | 2021 | 991 | 1.050 |
Why?
|
| Epilepsy | 11 | 2021 | 931 | 0.950 |
Why?
|
| Anticonvulsants | 4 | 2013 | 430 | 0.930 |
Why?
|
| Epilepsies, Partial | 9 | 2019 | 110 | 0.770 |
Why?
|
| Implantable Neurostimulators | 2 | 2018 | 18 | 0.720 |
Why?
|
| Epilepsy, Post-Traumatic | 4 | 2018 | 12 | 0.660 |
Why?
|
| Temporal Lobe | 6 | 2018 | 191 | 0.650 |
Why?
|
| Death, Sudden | 1 | 2018 | 56 | 0.590 |
Why?
|
| Epilepsy, Frontal Lobe | 5 | 2013 | 11 | 0.580 |
Why?
|
| Brain Injuries | 4 | 2009 | 776 | 0.500 |
Why?
|
| Mental Recall | 1 | 2015 | 171 | 0.480 |
Why?
|
| Brain | 14 | 2019 | 4208 | 0.450 |
Why?
|
| Gyrus Cinguli | 2 | 2013 | 127 | 0.430 |
Why?
|
| Breast Feeding | 1 | 2013 | 246 | 0.400 |
Why?
|
| Deep Brain Stimulation | 4 | 2019 | 403 | 0.390 |
Why?
|
| Seizures | 7 | 2021 | 1001 | 0.370 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2013 | 263 | 0.370 |
Why?
|
| Drug Resistant Epilepsy | 3 | 2019 | 217 | 0.360 |
Why?
|
| Periventricular Nodular Heterotopia | 2 | 2019 | 7 | 0.340 |
Why?
|
| Developmental Disabilities | 1 | 2013 | 697 | 0.320 |
Why?
|
| Functional Laterality | 6 | 2015 | 274 | 0.310 |
Why?
|
| Electrocorticography | 2 | 2019 | 79 | 0.300 |
Why?
|
| Coma | 1 | 2007 | 63 | 0.290 |
Why?
|
| Brain Waves | 2 | 2019 | 50 | 0.280 |
Why?
|
| Cerebral Cortex | 6 | 2019 | 623 | 0.230 |
Why?
|
| Neurosurgical Procedures | 3 | 2013 | 633 | 0.230 |
Why?
|
| Neuropsychological Tests | 5 | 2015 | 1145 | 0.220 |
Why?
|
| Sclerosis | 2 | 2015 | 76 | 0.210 |
Why?
|
| Apolipoproteins E | 1 | 2003 | 221 | 0.200 |
Why?
|
| Magnetic Resonance Imaging | 13 | 2019 | 7895 | 0.190 |
Why?
|
| Neurology | 2 | 2015 | 120 | 0.190 |
Why?
|
| Adult | 32 | 2021 | 82040 | 0.180 |
Why?
|
| Encephalitis Virus, St. Louis | 1 | 2000 | 18 | 0.180 |
Why?
|
| Encephalitis, St. Louis | 1 | 2000 | 21 | 0.170 |
Why?
|
| Electrodes, Implanted | 6 | 2019 | 185 | 0.170 |
Why?
|
| Neocortex | 2 | 2019 | 97 | 0.170 |
Why?
|
| Frameshift Mutation | 1 | 2020 | 234 | 0.160 |
Why?
|
| Male | 35 | 2021 | 128315 | 0.160 |
Why?
|
| Bradycardia | 1 | 2019 | 73 | 0.160 |
Why?
|
| RNA Splicing | 1 | 2020 | 361 | 0.150 |
Why?
|
| Motor Cortex | 2 | 1996 | 126 | 0.150 |
Why?
|
| Disease Outbreaks | 1 | 2000 | 405 | 0.140 |
Why?
|
| Female | 31 | 2020 | 148940 | 0.140 |
Why?
|
| Videotape Recording | 4 | 2004 | 75 | 0.140 |
Why?
|
| Young Adult | 10 | 2018 | 22251 | 0.140 |
Why?
|
| Humans | 49 | 2021 | 270740 | 0.130 |
Why?
|
| Middle Aged | 22 | 2021 | 90352 | 0.130 |
Why?
|
| Quality Improvement | 2 | 2015 | 914 | 0.130 |
Why?
|
| Electrocardiography, Ambulatory | 1 | 2015 | 71 | 0.120 |
Why?
|
| Dominance, Cerebral | 3 | 2017 | 75 | 0.120 |
Why?
|
| Autoimmune Diseases of the Nervous System | 1 | 2015 | 34 | 0.120 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2020 | 464 | 0.120 |
Why?
|
| Adolescent | 18 | 2018 | 32767 | 0.120 |
Why?
|
| RNA-Binding Proteins | 1 | 2020 | 1017 | 0.120 |
Why?
|
| Status Epilepticus | 2 | 2000 | 149 | 0.120 |
Why?
|
| Organ Size | 1 | 2015 | 692 | 0.110 |
Why?
|
| Brain Injuries, Traumatic | 1 | 2018 | 356 | 0.110 |
Why?
|
| Memory | 2 | 2009 | 445 | 0.110 |
Why?
|
| Hippocampus | 4 | 2019 | 919 | 0.110 |
Why?
|
| Nerve Tissue Proteins | 1 | 2020 | 1581 | 0.100 |
Why?
|
| Brain Mapping | 5 | 2017 | 624 | 0.100 |
Why?
|
| Prospective Studies | 7 | 2021 | 13414 | 0.100 |
Why?
|
| Laughter | 1 | 2011 | 10 | 0.100 |
Why?
|
| Unconsciousness | 1 | 2011 | 21 | 0.090 |
Why?
|
| Nephrolithiasis | 1 | 2010 | 14 | 0.090 |
Why?
|
| Electric Stimulation | 2 | 2011 | 453 | 0.090 |
Why?
|
| Fructose | 1 | 2010 | 67 | 0.090 |
Why?
|
| Academies and Institutes | 1 | 2011 | 96 | 0.090 |
Why?
|
| Pentobarbital | 1 | 1990 | 28 | 0.090 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2019 | 2617 | 0.090 |
Why?
|
| Veterans | 2 | 2021 | 1737 | 0.090 |
Why?
|
| Phenytoin | 1 | 1990 | 81 | 0.080 |
Why?
|
| Fear | 1 | 2011 | 253 | 0.080 |
Why?
|
| Head Injuries, Penetrating | 1 | 2009 | 6 | 0.080 |
Why?
|
| Diffuse Axonal Injury | 1 | 2009 | 10 | 0.080 |
Why?
|
| Neurons | 1 | 2020 | 2439 | 0.080 |
Why?
|
| Anterior Temporal Lobectomy | 1 | 2009 | 34 | 0.080 |
Why?
|
| Neuroprotective Agents | 1 | 2010 | 220 | 0.080 |
Why?
|
| Benzodiazepines | 1 | 1990 | 167 | 0.080 |
Why?
|
| Heterozygote | 2 | 2020 | 1056 | 0.080 |
Why?
|
| Delivery of Health Care | 1 | 2015 | 855 | 0.070 |
Why?
|
| Follow-Up Studies | 6 | 2017 | 15218 | 0.070 |
Why?
|
| Rehabilitation Centers | 1 | 2007 | 72 | 0.070 |
Why?
|
| Practice Guidelines as Topic | 2 | 2015 | 2400 | 0.070 |
Why?
|
| Cicatrix | 1 | 2009 | 187 | 0.070 |
Why?
|
| Treatment Outcome | 9 | 2015 | 33737 | 0.070 |
Why?
|
| Psychotropic Drugs | 1 | 2007 | 140 | 0.070 |
Why?
|
| Brain Concussion | 1 | 2009 | 214 | 0.070 |
Why?
|
| Memory Disorders | 1 | 2009 | 287 | 0.070 |
Why?
|
| Quality of Health Care | 1 | 2011 | 618 | 0.070 |
Why?
|
| Epilepsy, Complex Partial | 2 | 2017 | 19 | 0.070 |
Why?
|
| Cross-Sectional Studies | 1 | 2015 | 4492 | 0.060 |
Why?
|
| Aged | 7 | 2019 | 73333 | 0.060 |
Why?
|
| Retrospective Studies | 10 | 2015 | 39890 | 0.060 |
Why?
|
| Activities of Daily Living | 1 | 2007 | 539 | 0.060 |
Why?
|
| Pattern Recognition, Physiological | 1 | 2004 | 4 | 0.060 |
Why?
|
| Wechsler Scales | 1 | 2004 | 25 | 0.060 |
Why?
|
| Age of Onset | 4 | 2000 | 853 | 0.060 |
Why?
|
| Recovery of Function | 1 | 2007 | 681 | 0.060 |
Why?
|
| Substantia Nigra | 2 | 2000 | 41 | 0.060 |
Why?
|
| Glasgow Outcome Scale | 1 | 2003 | 48 | 0.050 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 2003 | 275 | 0.050 |
Why?
|
| Drug Implants | 1 | 2002 | 52 | 0.050 |
Why?
|
| Time Factors | 3 | 2015 | 13006 | 0.050 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2009 | 1690 | 0.050 |
Why?
|
| Epilepsy, Tonic-Clonic | 2 | 2017 | 16 | 0.050 |
Why?
|
| Longitudinal Studies | 2 | 2018 | 2057 | 0.050 |
Why?
|
| Feasibility Studies | 2 | 2017 | 2353 | 0.050 |
Why?
|
| Frontal Lobe | 3 | 1996 | 167 | 0.050 |
Why?
|
| Huntington Disease | 1 | 1982 | 149 | 0.050 |
Why?
|
| Neurosyphilis | 1 | 2000 | 15 | 0.050 |
Why?
|
| Axon Guidance | 1 | 2020 | 3 | 0.040 |
Why?
|
| Pregnancy | 1 | 2013 | 8130 | 0.040 |
Why?
|
| AIDS Dementia Complex | 1 | 2000 | 18 | 0.040 |
Why?
|
| Gene Frequency | 1 | 2003 | 1246 | 0.040 |
Why?
|
| Receptors, GABA-A | 2 | 1995 | 81 | 0.040 |
Why?
|
| Penicillins | 1 | 2000 | 170 | 0.040 |
Why?
|
| Brain Edema | 1 | 2000 | 95 | 0.040 |
Why?
|
| Muscle Hypotonia | 1 | 2020 | 188 | 0.040 |
Why?
|
| Video Recording | 1 | 2021 | 281 | 0.040 |
Why?
|
| Phenotype | 2 | 2009 | 6509 | 0.040 |
Why?
|
| Language Development Disorders | 1 | 2020 | 166 | 0.040 |
Why?
|
| Double-Blind Method | 2 | 2015 | 2580 | 0.040 |
Why?
|
| Clinical Trials as Topic | 1 | 2009 | 3844 | 0.040 |
Why?
|
| Receptors, Cell Surface | 1 | 1982 | 904 | 0.040 |
Why?
|
| Epilepsy, Partial, Motor | 1 | 2017 | 2 | 0.040 |
Why?
|
| Angelman Syndrome | 1 | 1998 | 77 | 0.040 |
Why?
|
| Genotype | 2 | 2003 | 4252 | 0.040 |
Why?
|
| Persian Gulf Syndrome | 1 | 1997 | 15 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 1998 | 231 | 0.040 |
Why?
|
| Zebrafish | 1 | 2020 | 457 | 0.040 |
Why?
|
| Long-Term Care | 1 | 2017 | 85 | 0.030 |
Why?
|
| Alternative Splicing | 1 | 2020 | 611 | 0.030 |
Why?
|
| Alleles | 1 | 2003 | 2600 | 0.030 |
Why?
|
| Defibrillators, Implantable | 1 | 2019 | 226 | 0.030 |
Why?
|
| Central Nervous System Diseases | 1 | 1997 | 134 | 0.030 |
Why?
|
| Radiography | 1 | 2000 | 1986 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2011 | 7783 | 0.030 |
Why?
|
| Electrodes | 2 | 1996 | 132 | 0.030 |
Why?
|
| Chromosome Disorders | 1 | 1998 | 423 | 0.030 |
Why?
|
| Hospitals, Teaching | 1 | 2015 | 125 | 0.030 |
Why?
|
| DNA | 1 | 2003 | 3050 | 0.030 |
Why?
|
| Reproducibility of Results | 2 | 2021 | 6177 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2020 | 2090 | 0.030 |
Why?
|
| Child, Preschool | 5 | 2020 | 17061 | 0.030 |
Why?
|
| Diagnostic Imaging | 1 | 2002 | 1174 | 0.030 |
Why?
|
| Monitoring, Intraoperative | 1 | 1996 | 264 | 0.030 |
Why?
|
| Age Factors | 2 | 2000 | 5457 | 0.030 |
Why?
|
| Early Diagnosis | 1 | 2015 | 313 | 0.030 |
Why?
|
| Propofol | 1 | 1994 | 77 | 0.030 |
Why?
|
| Immunomodulation | 1 | 2015 | 255 | 0.030 |
Why?
|
| Base Sequence | 1 | 2020 | 5437 | 0.030 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 1997 | 401 | 0.030 |
Why?
|
| Steroids | 1 | 1995 | 372 | 0.030 |
Why?
|
| Neurologic Examination | 3 | 2000 | 262 | 0.030 |
Why?
|
| Intellectual Disability | 1 | 2020 | 1065 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2020 | 5694 | 0.020 |
Why?
|
| Tomography, Emission-Computed | 1 | 1993 | 334 | 0.020 |
Why?
|
| Prognosis | 1 | 2009 | 22505 | 0.020 |
Why?
|
| Chromosome Aberrations | 1 | 1998 | 2035 | 0.020 |
Why?
|
| Texas | 1 | 2000 | 6449 | 0.020 |
Why?
|
| Drug Resistance | 1 | 1990 | 610 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2018 | 4372 | 0.020 |
Why?
|
| Educational Status | 1 | 2009 | 392 | 0.020 |
Why?
|
| Child | 7 | 2013 | 30559 | 0.020 |
Why?
|
| Risk Factors | 1 | 2003 | 17888 | 0.020 |
Why?
|
| Evidence-Based Medicine | 1 | 2011 | 1034 | 0.020 |
Why?
|
| Automatism | 2 | 1995 | 4 | 0.020 |
Why?
|
| Trauma Severity Indices | 1 | 2004 | 94 | 0.010 |
Why?
|
| Psychometrics | 1 | 2009 | 973 | 0.010 |
Why?
|
| Posture | 2 | 1995 | 190 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2011 | 2250 | 0.010 |
Why?
|
| Subdural Space | 2 | 1993 | 8 | 0.010 |
Why?
|
| Prevalence | 1 | 2010 | 3404 | 0.010 |
Why?
|
| Brain Neoplasms | 3 | 1994 | 4958 | 0.010 |
Why?
|
| Putamen | 1 | 1982 | 25 | 0.010 |
Why?
|
| Caudate Nucleus | 1 | 1982 | 42 | 0.010 |
Why?
|
| Subcellular Fractions | 1 | 1982 | 210 | 0.010 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 1982 | 279 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2004 | 2315 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2000 | 30998 | 0.010 |
Why?
|
| Observer Variation | 2 | 1993 | 709 | 0.010 |
Why?
|
| Quality of Life | 1 | 2014 | 4761 | 0.010 |
Why?
|
| Mice | 1 | 2020 | 35600 | 0.010 |
Why?
|
| Ligases | 1 | 1998 | 81 | 0.010 |
Why?
|
| United States | 2 | 2011 | 15861 | 0.010 |
Why?
|
| Nystagmus, Pathologic | 1 | 1997 | 24 | 0.010 |
Why?
|
| Genomic Imprinting | 1 | 1998 | 199 | 0.010 |
Why?
|
| Hematologic Tests | 1 | 1997 | 84 | 0.010 |
Why?
|
| Vestibular Function Tests | 1 | 1997 | 34 | 0.010 |
Why?
|
| Muscular Diseases | 1 | 1997 | 161 | 0.010 |
Why?
|
| Evoked Potentials | 1 | 1997 | 217 | 0.010 |
Why?
|
| Muscimol | 1 | 1995 | 15 | 0.010 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 1997 | 334 | 0.010 |
Why?
|
| Ataxia | 1 | 1997 | 182 | 0.010 |
Why?
|
| Autoradiography | 1 | 1995 | 154 | 0.010 |
Why?
|
| Animals | 1 | 2020 | 61956 | 0.010 |
Why?
|
| Occipital Lobe | 1 | 1995 | 47 | 0.010 |
Why?
|
| Diagnosis, Differential | 2 | 1995 | 4831 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 1998 | 1655 | 0.010 |
Why?
|
| Ganglioglioma | 1 | 1993 | 40 | 0.010 |
Why?
|
| Chromosome Deletion | 1 | 1998 | 1049 | 0.010 |
Why?
|
| Oligodendroglioma | 1 | 1993 | 105 | 0.010 |
Why?
|
| Arm | 1 | 1993 | 139 | 0.010 |
Why?
|
| Evoked Potentials, Somatosensory | 1 | 1993 | 67 | 0.010 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 1998 | 875 | 0.010 |
Why?
|
| Deoxyglucose | 1 | 1993 | 120 | 0.010 |
Why?
|
| Speech | 1 | 1993 | 136 | 0.010 |
Why?
|
| Head | 1 | 1993 | 248 | 0.010 |
Why?
|
| Eye | 1 | 1993 | 283 | 0.010 |
Why?
|
| Dystonia | 1 | 1993 | 172 | 0.010 |
Why?
|
| Probability | 1 | 1993 | 886 | 0.010 |
Why?
|
| Cognition Disorders | 1 | 1997 | 762 | 0.010 |
Why?
|
| Astrocytoma | 1 | 1993 | 326 | 0.010 |
Why?
|
| Binding Sites | 1 | 1995 | 2255 | 0.010 |
Why?
|
| Monitoring, Physiologic | 1 | 1993 | 512 | 0.010 |
Why?
|
| Sphenoid Bone | 1 | 1989 | 21 | 0.010 |
Why?
|
| Action Potentials | 1 | 1993 | 588 | 0.010 |
Why?
|
| Equipment Design | 1 | 1992 | 1197 | 0.000 |
Why?
|
| Chronic Disease | 1 | 1993 | 1824 | 0.000 |
Why?
|
| Scalp | 1 | 1989 | 155 | 0.000 |
Why?
|
| Infant | 2 | 1995 | 13999 | 0.000 |
Why?
|
| DNA Methylation | 1 | 1998 | 2765 | 0.000 |
Why?
|
| Case-Control Studies | 1 | 1997 | 6224 | 0.000 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 1993 | 1260 | 0.000 |
Why?
|
| Preoperative Care | 1 | 1993 | 1567 | 0.000 |
Why?
|
| Predictive Value of Tests | 1 | 1993 | 4960 | 0.000 |
Why?
|
| Incidence | 1 | 1993 | 5824 | 0.000 |
Why?
|
| Postoperative Complications | 1 | 1993 | 5681 | 0.000 |
Why?
|